The player is loading ...
March 4, 2024
Huntsville Hospital Cardiology Update 2024 Recap
Jody summarizes what he learned recently at the HH Cardiology Update 2024, held at UA Huntsville College of Nursing.
Resources:
- UAH Kinesiology CPET
- Nunn AVW, Guy GW, Brysch W, Bell JD. Understanding Long COVID; Mitochondrial Health and Adaptation-Old Pathways, New Problems. Biomedicines. 2022 Dec 2;10(12):3113. doi: 10.3390/biomedicines10123113. PMID: 36551869; PMCID: PMC9775339
- 2022 ACC/AHA Aortic Disease Guidelines
- StatPearls Water Hammer Pulse Article
- Water Hammer Toy Demo (YouTube)
- StatPearls COX Inhibitor Article
- AHA Anticoagulation Strategies for PCI
- Bivalirudin vs Heparin in STEMI
- Glycoprotein IIA/IIIB Inhibitors
- P2Y12 Inhibitors
- McLaughlin K, Rimsans J, Sylvester KW, Fanikos J, Dorfman DM, Senna P, Connors JM, Goldhaber SZ. Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy. Clin Appl Thromb Hemost. 2019 Jan Dec;25:10760296 19876030. doi: 10.1177/1076029619876030. PMID: 31530176; PMCID: PMC6829967.
- Cirillo P, Taglialatela V, Pellegrino G, Morello A, Conte S, Di Serafino L, Cimmino G. Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel. J Thromb Thrombolysis. 2020 Aug;50(2):468-472. doi: 10.1007/s11239-020-02121-8. PMID: 32335777; PMCID: PMC7183388.
- ESC Cardio-oncology Guidelines
- 2022 ESC Guidelines Key Points (ACC)
- ICOS Cardio-oncology Risk Assessment Tool
- Ibrutinib Associated Cardiotoxicity
- SPARC Tool
- ATRIUM Clinical Trial Information
- ACC Cardiosmart
- UAB ICOS
- UAB Cardio-oncology Program